Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2021-01-14 2020-11-06
Drug Identification Number 00577308 00577308
Brand name ZADITEN ZADITEN
Common or Proper name ZADITEN 1MG TABLETS ZADITEN 1MG TABLETS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients KETOTIFEN KETOTIFEN
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code R06AX R06AX
ATC description ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-04 2020-11-04
Estimated end date 2021-02-28 2020-12-31
Actual end date 2021-01-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments